Inhalable Capsular Polysaccharide‐Camouflaged Gallium‐Polyphenol Nanoparticles Enhance Lung Cancer Chemotherapy by Depleting Local Lung Microbiota
- 23 July 2023
- journal article
- research article
- Published by Wiley in Advanced Materials
- Vol. 35 (38) , e2302551
Abstract
Local lung microbiota is closely associated with lung tumorigenesis and therapeutic response. It is found that lung commensal microbes induce chemoresistance in lung cancer by directly inactivating therapeutic drugs via biotransformation. Accordingly, an inhalable microbial capsular polysaccharide (CP)‐camouflaged gallium‐polyphenol metal–organic network (MON) is designed to eliminate lung microbiota and thereby abrogate microbe‐induced chemoresistance. As a substitute for iron uptake, Ga3+ released from MON acts as a “Trojan horse” to disrupt bacterial iron respiration, effectively inactivating multiple microbes. Moreover, CP cloaks endow MON with reduced immune clearance by masquerading as normal host‐tissue molecules, significantly increasing residence time in lung tissue for enhanced antimicrobial efficacy. In multiple lung cancer mice models, microbe‐induced drug degradation is remarkably inhibited when drugs are delivered by antimicrobial MON. Tumor growth is sufficiently suppressed and mouse survival is prolonged. The work develops a novel microbiota‐depleted nanostrategy to overcome chemoresistance in lung cancer by inhibiting local microbial inactivation of therapeutic drugs.Keywords
Funding Information
- National Natural Science Foundation of China (22135005, 51988102, 51833007)
- National Key Research and Development Program of China (2019YFA0905603)
This publication has 45 references indexed in Scilit:
- Pneumococcal Capsules and Their Types: Past, Present, and FutureClinical Microbiology Reviews, 2015
- Cancer and the microbiotaScience, 2015
- Cancer and the gut microbiota: An unexpected linkScience Translational Medicine, 2015
- The gut microbiota, bacterial metabolites and colorectal cancerNature Reviews Microbiology, 2014
- Repurposing of gallium‐based drugs for antibacterial therapyBioFactors, 2014
- Chemotherapy, chemoresistance and the changing treatment landscape for NSCLCLung Cancer, 2011
- Alleviating Cancer Drug Toxicity by Inhibiting a Bacterial EnzymeScience, 2010
- Inhibition of lung tumor growth by complex pulmonary delivery of drugs with oligonucleotides as suppressors of cellular resistanceProceedings of the National Academy of Sciences, 2010
- Antibiotic Use and the Risk of Lung CancerCancer Epidemiology, Biomarkers & Prevention, 2008
- Epithelial NF-κB activation promotes urethane-induced lung carcinogenesisProceedings of the National Academy of Sciences, 2007